Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

‘Father of modern cardiology’ dies at 96 | High-risk women missing out on care | Tirzepatide beneficial for TAVR & PCI patients

News You Need to Know Today
‘Father of modern cardiology’ dies at 96 | High-risk women missing out on care | Tirzepatide beneficial for TAVR & PCI patients
Monday, April 27, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

‘Father of modern cardiology’ Eugene Braunwald dies at 96

Colleagues from all over the world have shared loving tributes to Braunwald. ESC President Thomas F. Lüscher, MD, called him "the pioneering cardiologist of his time."

READ MORE >
Eugene Braunwald, MD
Share on Twitter Share on Facebook Share on Linkedin

‘Father of modern cardiology’ Eugene Braunwald dies at 96

Share on Twitter Share on Facebook Share on Linkedin
Eugene Braunwald, MD
Colleagues from all over the world have shared loving tributes to Braunwald. ESC President Thomas F. Lüscher, MD, called him "the pioneering cardiologist of his time."
READ MORE >

Many high-risk pregnant patients still miss out on guideline-recommended care

The percentage of pregnant patients taking low-dose aspirin as recommended is slowly rising—but there is still a long way to go.

READ MORE >
Emily Lau, MD, MPH, Director, Women's Heart Health Program, Brigham and Women's Hospital, presented new data at ACC 2026 showing only 8% of high-risk pregnant patients receive guideline-recommended low-dose aspirin to prevent preeclampsia.
Share on Twitter Share on Facebook Share on Linkedin

Many high-risk pregnant patients still miss out on guideline-recommended care

Share on Twitter Share on Facebook Share on Linkedin
Emily Lau, MD, MPH, Director, Women's Heart Health Program, Brigham and Women's Hospital, presented new data at ACC 2026 showing only 8% of high-risk pregnant patients receive guideline-recommended low-dose aspirin to prevent preeclampsia.
The percentage of pregnant patients taking low-dose aspirin as recommended is slowly rising—but there is still a long way to go.
READ MORE >

Popular weight loss drug linked to key benefits for patients undergoing TAVR, PCI

Two separate studies explored the value of treating heart patients with tirzepatide. 

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

Popular weight loss drug linked to key benefits for patients undergoing TAVR, PCI

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
Two separate studies explored the value of treating heart patients with tirzepatide. 
READ MORE >

Featured Articles

Trump administration moves to speed up Medicare coverage for breakthrough cardiology devices

CMS and the FDA say the goal is to improve patient access to medical devices that address an unmet need.

READ MORE >
approval regulations checkmark doctor
Share on Twitter Share on Facebook Share on Linkedin

Trump administration moves to speed up Medicare coverage for breakthrough cardiology devices

Share on Twitter Share on Facebook Share on Linkedin
approval regulations checkmark doctor
CMS and the FDA say the goal is to improve patient access to medical devices that address an unmet need.
READ MORE >

Researchers use multi-modality imaging to learn more about MINOCA

The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.

READ MORE >
Harmony Reynolds, MD, FACC, director of the cardiovascular clinical research center at NYU Langone Health, presented a study at the American College of Cardiology (ACC) 2026 meeting using coronary optical coherence tomography (OCT) and cardiac magnetic resonance imaging (MRI) to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries (MINOCA).
Share on Twitter Share on Facebook Share on Linkedin

Researchers use multi-modality imaging to learn more about MINOCA

Share on Twitter Share on Facebook Share on Linkedin
Harmony Reynolds, MD, FACC, director of the cardiovascular clinical research center at NYU Langone Health, presented a study at the American College of Cardiology (ACC) 2026 meeting using coronary optical coherence tomography (OCT) and cardiac magnetic resonance imaging (MRI) to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries (MINOCA).
The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.
READ MORE >

First bedside procedure of its kind performed by traveling clinicians on premature infant

The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.

READ MORE >
Nicklaus Children’s Hospital patent ductus arteriosus (PDA) closure
Share on Twitter Share on Facebook Share on Linkedin

First bedside procedure of its kind performed by traveling clinicians on premature infant

Share on Twitter Share on Facebook Share on Linkedin
Nicklaus Children’s Hospital patent ductus arteriosus (PDA) closure
The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.
READ MORE >

FDA approves 2 implantable heart devices from Biotronik

These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago. 

READ MORE >
 The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026
Share on Twitter Share on Facebook Share on Linkedin

FDA approves 2 implantable heart devices from Biotronik

Share on Twitter Share on Facebook Share on Linkedin
 The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026
These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago. 
READ MORE >

In Case You Missed It

Key clinical takeaways from ACC.26

Hadley Wilson, MD, a former American College of Cardiology president, spoke to Cardiovascular Business about several studies presented at ACC.26.

READ MORE >
 Former American College of Cardiology president Hadley Wilson, MD, FACC, executive vice chair of Atrium Health's Sanger Heart and Vascular Institute, shared his thoughts on what he saw as the key studies in the above video interview with Cardiovascular Business. He covered numerous trials in more detail in the video. #ACC26 #ACC
Share on Twitter Share on Facebook Share on Linkedin

Key clinical takeaways from ACC.26

Share on Twitter Share on Facebook Share on Linkedin
 Former American College of Cardiology president Hadley Wilson, MD, FACC, executive vice chair of Atrium Health's Sanger Heart and Vascular Institute, shared his thoughts on what he saw as the key studies in the above video interview with Cardiovascular Business. He covered numerous trials in more detail in the video. #ACC26 #ACC
Hadley Wilson, MD, a former American College of Cardiology president, spoke to Cardiovascular Business about several studies presented at ACC.26.
READ MORE >

FDA confirms another recall for Johnson & Johnson’s Impella heart pumps

More than 33,000 devices are affected by this recall. Customers may need to return and replace the purge cassettes included with their devices due to a risk of serious injury or death. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA confirms another recall for Johnson & Johnson’s Impella heart pumps

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
More than 33,000 devices are affected by this recall. Customers may need to return and replace the purge cassettes included with their devices due to a risk of serious injury or death. 
READ MORE >

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

READ MORE >
robot reviewing heart data
Share on Twitter Share on Facebook Share on Linkedin

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

Share on Twitter Share on Facebook Share on Linkedin
robot reviewing heart data
AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.
READ MORE >

In Other News

Users on a Discord chat are playing with Mythos, an AI deemed too dangerous for the public

Developer Anthropic released the tool to a small number of organizations in hopes they can find security vulnerabilities. Now comes a report revealing that a group of people on the popular Discord chat app have gained access. Mythos could be used as a powerful cybersecurity weapon.

READ MORE >
artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Users on a Discord chat are playing with Mythos, an AI deemed too dangerous for the public

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI in healthcare
Developer Anthropic released the tool to a small number of organizations in hopes they can find security vulnerabilities. Now comes a report revealing that a group of people on the popular Discord chat app have gained access. Mythos could be used as a powerful cybersecurity weapon.
READ MORE >

Interventional radiologists launch new chain of standalone outpatient IR centers

Co-founders Jonathan Steinberger, MD, and Gabriel Lipshutz, MD, are starting Elmnt IR with an initial location in Los Angeles and more to follow.  

READ MORE >
business launch
Share on Twitter Share on Facebook Share on Linkedin

Interventional radiologists launch new chain of standalone outpatient IR centers

Share on Twitter Share on Facebook Share on Linkedin
business launch
Co-founders Jonathan Steinberger, MD, and Gabriel Lipshutz, MD, are starting Elmnt IR with an initial location in Los Angeles and more to follow.  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

News Alert: FDA shares new warning about Impella heart pumps after death
AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure
Insulin pods recalled | Cardiology groups support bill | Treating ‘broken hearts’ | AI delivers answers | Prasugrel after PCI
The high costs of robotic tech | Medtronic recalls thousands of devices | TAVR in younger patients | FDA approves next-gen valve
Heart pump controllers recalled | Concomitant EP procedures for AFib | FDA's update after deaths | Pacing techniques & TAVR
The risks of PFA | FDA's warning after patient death | Cardiac ablations in ASCs | Group wants TAVR changes
How TAVR implant depth impacts outcomes | A closer look at GLP-1 drugs & AFib | BATMAN technique to the rescue

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup